Corvus Pharmaceuticals, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Corvus Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -54 %, a 24.2% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2023 was -59.6 %, a 4.98% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2022 was -56.8 %, a 29.1% decline from 2021.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2021 was -44 %, a 314% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -59.6 -2.83 -4.98% Jan 1, 2023 Dec 31, 2023
2022 -56.8 -12.8 -29.1% Jan 1, 2022 Dec 31, 2022
2021 -44 -33.4 -314% Jan 1, 2021 Dec 31, 2021
2020 -10.6 +44 +80.5% Jan 1, 2020 Dec 31, 2020
2019 -54.6 -16.6 -43.6% Jan 1, 2019 Dec 31, 2019
2018 -38 +17.4 +31.4% Jan 1, 2018 Dec 31, 2018
2017 -55.4 -30.4 -121% Jan 1, 2017 Dec 31, 2017
2016 -25.1 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.